Logo Image
News|Podcasts|January 30, 2025

The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations

Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.

In this episode of the Pharmaceutical Executive podcast, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses:

  • The challenges of addressing fertility misinformation on social media
  • The importance of providing accurate and reliable information
  • The importance of consulting with healthcare professionals
  • The ethical considerations of using social media to share personal and professional experiences
  • and so much more!

Related to this article

View more
Pharmaceutical Executive daily
Pharmaceutical Executive Daily: Peptide Ruling Stalls
Novo Nordisk data show real-world weight loss after switching to its oral semaglutide pill, FDA's peptide rulemaking stalls while its enforcement arm targets compounded peptide sellers, and Avi Pardo flags a compliance blind spot in field teams' text messages with doctors.
Read more
Pharmaceutical Executive daily
Pharmaceutical Executive Daily: FDA Approves Welireg Plus Lenvima
FDA approves Merck and Eisai's Welireg-Lenvima combination for advanced kidney cancer, a platform-deal roundup covers Novo Nordisk, Genentech, and Roche's tie-ups with Nanexa, Earendil Labs, and Atavistik Bio, and Ron Lanton examines the fight to regulate pharmacy benefit managers.
Read more
Pharmaceutical executive daily
Pharmaceutical Executive Daily: FDA Approves Onswik
InnoCare Pharma and Eli Lilly ink a multibillion-dollar research collaboration, FDA approves Lilly's once-weekly insulin Onswik for type 2 diabetes, and Jen Lamppa talks fixing clinical trial patient enrollment with real-world data.
Read more